Alumni Publications

2018

Varughese T, Taur Y, Cohen N, M Palomba L, Seo SK, Hohl TM, Redelman-Sidi G.  2018.  Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Malignancies.. Clin Infect Dis.
Mahmood U, Ahn S, Yang E-J, Choi M, Kim H, Regan P, Cho K, Kim H-S.  2018.  Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder.. Pharmacol Res. 128:110-121.
Czarnowicki T, He HY, Wen H-C, Hashim PW, Nia JK, Malik K, Estrada Y, Kimmel GW, Taliercio M, Krueger JG et al..  2018.  Alopecia areata is characterized by expansion of circulating Th2/Tc2/Th22, within the skin-homing and systemic T-cell populations.. Allergy. 73(3):713-723.
Pullabhatla V, Roberts AL, Lewis MJ, Mauro D, Morris DL, Odhams CA, Tombleson P, Liljedahl U, Vyse S, Simpson MA et al..  2018.  De novo mutations implicate novel genes in systemic lupus erythematosus.. Hum Mol Genet. 27(3):421-429.
Brownlee RD, Ardeshir A, Becker MD, Wagner AM, Besselsen DG.  2018.  A field strain of minute virus of mice (MVMm) exhibits age- and strain-specific pathogenesis.. J Gen Virol. 99(4):558-566.
Packer RJ, Fisher MJ, Cutter G, Cole-Plourde K, Korf BR.  2018.  Neurofibromatosis Clinical Trial Consortium.. J Child Neurol. 33(1):82-91.
Dulaney ES, Graupmann V, Grant KE, Adam EK, Chen E.  2018.  Taking on the stress-depression link: Meaning as a resource in adolescence.. J Adolesc. 65:39-49.
Koczkowska M, Chen Y, Callens T, Gomes A, Sharp A, Johnson S, Hsiao M-C, Chen Z, Balasubramanian M, Barnett CP et al..  2018.  Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.. Am J Hum Genet. 102(1):69-87.
Ma W, Fu F, Zhu J, Huang R, Zhu Y, Liu Z, Wang J, Conti PS, Shi X, Chen K.  2018.  Cu-Labeled multifunctional dendrimers for targeted tumor PET imaging.. Nanoscale. 10(13):6113-6124.
Lin H, Wei S, Hurt EM, Green MD, Zhao L, Vatan L, Szeliga W, Herbst R, Harms PW, Fecher LA et al..  2018.  Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.. J Clin Invest. 128(2):805-815.